Lisata Therapeutics Revenue, Growth & Competitor Profile

DBA CALADRIUS BIOSCIENCES
DBA NEOSTEM

Company Profile & Annual Report for Lisata Therapeutics

Access the complete profile.

Lisata Therapeutics Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	621511 Medical Laboratories
Additional NAICS Codes	5417 Scientific Research & Development Services 541711 Research & Development in Biotechnology
Address	110 Allen Rd Fl 2 Basking Ridge, NJ 07920

Note: Revenues for privately held companies are statistical evaluations.


Lisata Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Lisata Therapeutics's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Lisata Therapeutics is classified as operating in the Medical Laboratories industry, NAICS Code 621511.

Lisata Therapeutics Annual Revenue and Growth Rate

Lisata Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$1 - $10 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Lisata Therapeutics's revenues are gauged from an analysis of company filings.

Lisata Therapeutics's Income Statement (based on Industry Averages)

Lisata Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Lisata Therapeutics is developing and marketing. Lisata Therapeutics doesn't have any recent trademark applications, indicating Lisata Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
LISATA Pharmaceutical preparations for use in cancer, tumors, diabetic kidney disease, coronary microvascular dysfunction, Buerger's Disease, and Critical Limb Ischemia; Pharmaceutical preparations for use in treating and managing diseases, disorders, and conditions involving oncology, cardiology, vascular system, and ischemia; Therapeutic pharmaceutical preparations for enhancing the targeting, delivery, and effectiveness of cancer treatments; Therapeutic agents for promoting ischematic repair, regenerating damaged tissue, stimulating the repair or growth of microvasculature, penetrating tissue surrounding tumors, and altering immunosuppressive tumor microenvironments	04/22/2022
XOWNA Stem cell therapy services	01/29/2021
OLOGO Stem cell therapy services	02/07/2020

See all trademarks and details in the Full Report.

Market Share of Lisata Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Lisata Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
PHYSICIANS IMMUNODIAGNOSTIC LABORATORY	Burbank, CA	100
ACCU REFERENCE MEDICAL LAB LIMITED LIABILITY	Linden, NJ	100
CENTOGENE US	Cambridge, MA	88
LATARA ENTERPRISE	Pomona, CA	61
TELIGENT PHARMA	Vineland, NJ	46
COVID CLINIC	Huntington Beach, CA	37
VIKOR SCIENTIFIC	Charleston, SC	33
BIOTHERANOSTICS	San Diego, CA	31
SHERMAN-ABRAMS LABORATORY	Brooklyn, NY	31

Nearby Competitors

These companies are similar in business line and location to Lisata Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
EVOLUTION RESEARCH GROUP	New Providence, NJ	100
KUWATA PAN DENT	Cedar Knolls, NJ	6
INFECTIOUS DISEASE CENTEROF NEW JERSEY	Whippany, NJ	4
LISATA THERAPEUTICS	Basking Ridge, NJ	4
MOLESAFE USA	Florham Park, NJ	2
INPECO NORTH	East Hanover, NJ	2

Future Competition: Lisata Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Lisata Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)